BCRX
Biocryst Pharmaceuticals
$9.58
+$0.24 (+2.57%)Jul 27, 2026
Key metrics
The numbers that frame BCRX today
- Market cap
- $2.43B
- P/E (TTM)
- -5.3
- EV / FCF
- 10.1
- Gross margin
- 97.8%
- EV / Sales
- 3.5
- ROIC
- -44%
- Div yield
- 0%
- 52wk Low
- $6.00
- 52wk High
- $11.22
Growth
Revenue and earnings trend for BCRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BCRX
Is Biocryst Pharmaceuticals a good buy?
Yes. Biocryst Pharmaceuticals has excellent quality and excellent momentum. Both signals support the setup. Growth looks poor, a caveat that does not overturn the setup. We think Biocryst Pharmaceuticals is selling at a fair price.
What is the market capitalization of BCRX?
Biocryst Pharmaceuticals's market capitalization is $2.43B.
What is the P/E ratio for BCRX stock?
Biocryst Pharmaceuticals's current P/E ratio is -5.3.
What is the 52-week high for BCRX stock?
The 52-week high for Biocryst Pharmaceuticals is $11.22. The current close of $9.58 is 14.6% below that high.
What is the 52-week low for BCRX stock?
The 52-week low for Biocryst Pharmaceuticals is $6.00. The current close of $9.58 is 59.7% above that low.
Does BCRX stock pay dividends?
Biocryst Pharmaceuticals does not currently show a dividend per share in the company data.